Upload Image (Max 20MB per Image)
Azelon Pharmaceuticals has completed a phase 2a trial comparing nasal spray ZT-034 to Forteo administered by subcutaneous injection and placebo in women with low bone mass. Patients in the phase 2 study, which saw the enrollment of 130 ...
Tags: Azelon Pharmaceuticals, low bone mass, bone formation